نتایج جستجو برای: acute myeloid leukemia

تعداد نتایج: 704270  

Journal: :Haematologica 2014
Julie Damgaard Sandahl Eva A Coenen Erik Forestier Jochen Harbott Bertil Johansson Gitte Kerndrup Souichi Adachi Anne Auvrignon H Berna Beverloo Jean-Michel Cayuela Lucy Chilton Maarten Fornerod Valérie de Haas Christine J Harrison Hiroto Inaba Gertjan J L Kaspers Der-Cherng Liang Franco Locatelli Riccardo Masetti Christine Perot Susana C Raimondi Katarina Reinhardt Daisuke Tomizawa Nils von Neuhoff Marco Zecca C Michel Zwaan Marry M van den Heuvel-Eibrink Henrik Hasle

Acute myeloid leukemia with t(6;9)(p22;q34) is listed as a distinct entity in the 2008 World Health Organization classification, but little is known about the clinical implications of t(6;9)-positive myeloid leukemia in children. This international multicenter study presents the clinical and genetic characteristics of 62 pediatric patients with t(6;9)/DEK-NUP214-rearranged myeloid leukemia; 54 ...

Journal: :international journal of hematology-oncology and stem cell research 0
arash jalali department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran ; hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran. kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran. mahmood mahmoudi department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. kazem mohammad department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. hojjat zeraati department of epidemiology and biostatistics, school of public health, tehran university of medical sciences, tehran, iran. seied asadollah mousavi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.

the aim of this study was to assess the predictive effect of the ebmt risk score on the outcomes of allogeneic stem cell transplantation in a relatively homogenous group of acute myelogenous leukemia (aml) patients regarding the occurrence of acute and chronic graft versus host disease (gvhd). this historical cohort study included adult patients (≥ 15 years old) with aml (n=363) who received al...

Journal: :Anticancer research 2005
Nagio Takigawa Makoto Takeuchi Takuo Shibayama Isao Yoshida Noriko Kawata Atsuhiko Tada Hiroshi Ueoka Kiyoshi Takahashi

There are few reports describing simultaneous occurrence of acute leukemia and lung cancer. We describe here an 83-year-old woman who simultaneously developed advanced adenocarcinoma of the lung and acute myeloid leukemia. She could not receive intensive chemotherapy due to poor performance status. This patient was treated with a combination of gefitinib, low-dose cytarabine and aclarubicin. Th...

Journal: :Haematologica 2012
Giorgio Zauli Claudio Celeghini Elisabetta Melloni Rebecca Voltan Manuele Ongari Mario Tiribelli Maria Grazia di Iasio Francesco Lanza Paola Secchiero

BACKGROUND Both the multi-kinase inhibitor sorafenib and the small molecule inhibitor of the MDM2/p53 interaction, nutlin-3, used alone, have shown promising anti-leukemic activity in acute myeloid leukemia cells. Thus, in this study we investigated the effect of the combination of sorafenib plus nutlin-3 in acute myeloid leukemia. DESIGN AND METHODS Primary acute myeloid leukemia blasts (n=1...

Journal: :Haematologica 2016
Raajit Rampal Maria E Figueroa

Wilms tumor 1 (WT1) has long been implicated in acute myeloid leukemia. It has been described to be both overexpressed and mutated in different forms of acute myeloid leukemia, and overexpression has been reported to play a prognostic role in this disease. However, the precise mechanism through which WT1 may play a role in leukemogenesis has remained elusive. In recent years, new evidence has e...

Journal: :Journal of investigative medicine high impact case reports 2017
Mayur D Mody Deepak Ravindranathan Harpaul S Gill Vamsi K Kota

Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started...

Journal: :Haematologica 2009
Ulrich Langenkamp Uwe Siegler Simon Jörger Stefan Diermayr Alois Gratwohl Christian P Kalberer Aleksandra Wodnar-Filipowicz

The concept of tumor immunosurveillance has raised prospects for natural killer cell-based immunotherapy of human cancer. The cure of acute myeloid leukemia may depend on eradication of leukemic stem cells, the self-renewing component of leukemia. Whether natural killer cells can recognize and lyse leukemic stem cells is not known. To develop strategies that effectively target acute myeloid leu...

Nematolahy, Pardis , Reisi, Nahid ,

The development of secondary malignancy (SM) is the most worrisome long-term complication of childhood cancer. Acute myeloid leukemia is the most prevalent neoplasm that occurs after treatment with alkylating agents and topoisomerase II inhibitors. Pleuropulmonary blastoma (PPB) is a rare lung neoplasm in children. Type II and type III of this cancer are markedly aggressive and have a recurrent...

Journal: :Haematologica 2011
Bárbara Amélia Santana-Lemos Ana Paula Alencar de Lima Lange Mariana Tereza de Lira Benício Thiago Donizete da Silva José Antônio Roberto Lucena-Araújo Alexandre Krause Carolina Hassibe Thomé Eduardo Magalhães Rego

Impairment of CCAAT Enhancer Binding Protein alpha (CEBPA) function is a common finding in acute myeloid leukemia; nevertheless, its relevance for acute promyelocytic leukemia pathogenesis is unclear. We analyzed the expression and assessed the methylation status of the core and upstream promoters of CEBPA in acute promyelocytic leukemia at diagnosis. Patients with acute promyelocytic leukemia ...

Journal: :international journal of hematology-oncology and stem cell research 0
marjan yaghmaie medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran hossein mozdarani medical genetics department, faculty of medical sciences, tarbiat modares university, tehran, iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran seyed hamiollah ghaffari hematology, oncology and stem cell transplantation research center, shariati hospital, tehran university, tehran, iran

introduction: the secondary genetic changes other than the pml-rara fusion gene may contribute to the acute promyelocytic leukemogenesis. chromosomal alterations and mutation of flt3 tyrosine kinase receptor are the frequent genetic alterations in acute myeloid leukemia (aml). however, the prognostic significance of flt3 mutations in acute promyelocytic leukemia (apl) is not firmly established....

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید